Edwards Wildman Palmer LLP
Macrocyclic hepatitis C serine protease inhibitors
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
AbbVie, Inc.
C C A A A A
C07K C07D A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional
Brian E. Jason P. Albert W. Steven C. Yonghua Hui-Ju Jorge Russell D. Dennie S. Guoqiang Keith F. Yat Sun
Green Shanley Kruger Cullen Gai Chen Gandarllla Cink Welch Wang McDaniel Or